Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephanie Finzel

Showing results (61-70 of 84) with videos related to

Pageof 9
Sort By:
Science Translational Medicine|April 19, 2016
Chronic skin inflammation leads to bone loss by IL-17-mediated inhibition of Wnt signaling in osteoblastsÖzge Uluçkan, Maria Jimenez, Susanne Karbach, et al.
The Journal of Rheumatology|September 16, 2020
Reliability and Change in Erosion Measurements by High-resolution Peripheral Quantitative Computed Tomography in a Longitudinal Dataset of Rheumatoid Arthritis PatientsStephanie Finzel, Sarah L Manske, Cheryl C M Barnabe, et al.
The Journal of Rheumatology|November 1, 2023
The Novel OMERACT Ultrasound Scoring System for Salivary Gland Changes in Patients With Sjögren Syndrome Is Associated With MRI and Salivary Flow RatesNevsun Inanc, Sandrine Jousse-Joulin, Kerem Abacar, et al.
The Lancet. Rheumatology|January 22, 2024
Safety and efficacy of secukinumab in patients with giant cell arteritis (TitAIN): a randomised, double-blind, placebo-controlled, phase 2 trialNils Venhoff, Wolfgang A Schmidt, Raoul Bergner, et al.
The Journal of Rheumatology|March 17, 2015
The OMERACT Ultrasound Working Group 10 Years On: Update at OMERACT 12George A Bruyn, Esperanza Naredo, Annamaria Iagnocco, et al.
Zeitschrift Fur Rheumatologie|March 19, 2026
[Proposal of the rheumatology societies in the D-A-CH region for a uniform German nomenclature for Sjögren's disease]Diana Ernst, , Thomas Dörner, et al.
Lancet (London, England)|August 3, 2024
Safety and efficacy of subcutaneous iscalimab (CFZ533) in two distinct populations of patients with Sjögren's disease (TWINSS): week 24 results of a randomised, double-blind, placebo-controlled, phase 2b dose-ranging studyBenjamin A Fisher, Xavier Mariette, Athena Papas, et al.
Annals of the Rheumatic Diseases|February 10, 2015
Relapse rates in patients with rheumatoid arthritis in stable remission tapering or stopping antirheumatic therapy: interim results from the prospective randomised controlled RETRO studyJudith Haschka, Matthias Englbrecht, Axel J Hueber, et al.
The Journal of Rheumatology|December 4, 2018
Cost-effective Tapering Algorithm in Patients with Rheumatoid Arthritis: Combination of Multibiomarker Disease Activity Score and Autoantibody StatusMelanie Hagen, Matthias Englbrecht, Judith Haschka, et al.
Annals of the Rheumatic Diseases|October 21, 2015
Prediction of disease relapses by multibiomarker disease activity and autoantibody status in patients with rheumatoid arthritis on tapering DMARD treatmentJuergen Rech, Axel J Hueber, Stephanie Finzel, et al.
Pageof 9

Showing results (61-70 of 84) with videos related to

Sort By:
Pageof 9
Science Translational Medicine|April 19, 2016
Chronic skin inflammation leads to bone loss by IL-17-mediated inhibition of Wnt signaling in osteoblastsÖzge Uluçkan, Maria Jimenez, Susanne Karbach, et al.
The Journal of Rheumatology|September 16, 2020
Reliability and Change in Erosion Measurements by High-resolution Peripheral Quantitative Computed Tomography in a Longitudinal Dataset of Rheumatoid Arthritis PatientsStephanie Finzel, Sarah L Manske, Cheryl C M Barnabe, et al.
The Journal of Rheumatology|November 1, 2023
The Novel OMERACT Ultrasound Scoring System for Salivary Gland Changes in Patients With Sjögren Syndrome Is Associated With MRI and Salivary Flow RatesNevsun Inanc, Sandrine Jousse-Joulin, Kerem Abacar, et al.
The Lancet. Rheumatology|January 22, 2024
Safety and efficacy of secukinumab in patients with giant cell arteritis (TitAIN): a randomised, double-blind, placebo-controlled, phase 2 trialNils Venhoff, Wolfgang A Schmidt, Raoul Bergner, et al.
The Journal of Rheumatology|March 17, 2015
The OMERACT Ultrasound Working Group 10 Years On: Update at OMERACT 12George A Bruyn, Esperanza Naredo, Annamaria Iagnocco, et al.
Zeitschrift Fur Rheumatologie|March 19, 2026
[Proposal of the rheumatology societies in the D-A-CH region for a uniform German nomenclature for Sjögren's disease]Diana Ernst, , Thomas Dörner, et al.
Lancet (London, England)|August 3, 2024
Safety and efficacy of subcutaneous iscalimab (CFZ533) in two distinct populations of patients with Sjögren's disease (TWINSS): week 24 results of a randomised, double-blind, placebo-controlled, phase 2b dose-ranging studyBenjamin A Fisher, Xavier Mariette, Athena Papas, et al.
Annals of the Rheumatic Diseases|February 10, 2015
Relapse rates in patients with rheumatoid arthritis in stable remission tapering or stopping antirheumatic therapy: interim results from the prospective randomised controlled RETRO studyJudith Haschka, Matthias Englbrecht, Axel J Hueber, et al.
The Journal of Rheumatology|December 4, 2018
Cost-effective Tapering Algorithm in Patients with Rheumatoid Arthritis: Combination of Multibiomarker Disease Activity Score and Autoantibody StatusMelanie Hagen, Matthias Englbrecht, Judith Haschka, et al.
Annals of the Rheumatic Diseases|October 21, 2015
Prediction of disease relapses by multibiomarker disease activity and autoantibody status in patients with rheumatoid arthritis on tapering DMARD treatmentJuergen Rech, Axel J Hueber, Stephanie Finzel, et al.
Pageof 9